Company Filing History:
2 out of 3,539 
2 out of 1,220 
Years Active: 2017-2019
Title: Changtao Jiang: Innovator in Farnesoid X Receptor Inhibitors
Introduction
Changtao Jiang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the development of inhibitors for the farnesoid X receptor. With a total of 2 patents, his work focuses on addressing critical health issues such as obesity and type 2 diabetes.
Latest Patents
Changtao Jiang's latest patents include innovative inhibitors of the farnesoid X receptor. These inhibitors are designed to treat or prevent obesity, type 2 diabetes, insulin resistance, and non-alcoholic fatty liver disease in mammals. The patents disclose a composition that comprises a pharmaceutically suitable carrier and at least one compound of the invention. Additionally, methods for inhibiting the farnesoid X receptor and treating obesity in mammals are also outlined in these patents.
Career Highlights
Throughout his career, Changtao Jiang has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Penn State Research Foundation. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Changtao Jiang has collaborated with notable colleagues, including Frank J Gonzalez and Cen Xie. These partnerships have further enhanced his research and development efforts in the field of medicine.
Conclusion
Changtao Jiang is a distinguished inventor whose work on farnesoid X receptor inhibitors has the potential to significantly impact the treatment of obesity and related health conditions. His contributions to medical research continue to pave the way for innovative solutions in healthcare.